
Aaron A. Priest
Examiner (ID: 4927, Phone: (571)270-1095 , Office: P/1637 )
| Most Active Art Unit | 1637 |
| Art Unit(s) | 1681, 1637 |
| Total Applications | 1183 |
| Issued Applications | 754 |
| Pending Applications | 117 |
| Abandoned Applications | 354 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16933780
[patent_doc_number] => 20210199669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => PROTEIN AND GENE BIOMARKERS FOR REJECTION OF ORGAN TRANSPLANTS
[patent_app_type] => utility
[patent_app_number] => 17/162093
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19414
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17162093
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/162093 | Protein and gene biomarkers for rejection of organ transplants | Jan 28, 2021 | Issued |
Array
(
[id] => 18274853
[patent_doc_number] => 11613788
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-28
[patent_title] => Detection of nucleic acids from multiple types of human papillomavirus
[patent_app_type] => utility
[patent_app_number] => 17/161923
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16153
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17161923
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/161923 | Detection of nucleic acids from multiple types of human papillomavirus | Jan 28, 2021 | Issued |
Array
(
[id] => 19013263
[patent_doc_number] => 11920181
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Nuclease profiling system
[patent_app_type] => utility
[patent_app_number] => 17/160329
[patent_app_country] => US
[patent_app_date] => 2021-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 176
[patent_no_of_words] => 34713
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17160329
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/160329 | Nuclease profiling system | Jan 26, 2021 | Issued |
Array
(
[id] => 16992162
[patent_doc_number] => 20210230582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => COMPOSITIONS AND KITS FOR MOLECULAR COUNTING
[patent_app_type] => utility
[patent_app_number] => 17/157872
[patent_app_country] => US
[patent_app_date] => 2021-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45369
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17157872
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/157872 | COMPOSITIONS AND KITS FOR MOLECULAR COUNTING | Jan 24, 2021 | Pending |
Array
(
[id] => 16992162
[patent_doc_number] => 20210230582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => COMPOSITIONS AND KITS FOR MOLECULAR COUNTING
[patent_app_type] => utility
[patent_app_number] => 17/157872
[patent_app_country] => US
[patent_app_date] => 2021-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45369
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17157872
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/157872 | COMPOSITIONS AND KITS FOR MOLECULAR COUNTING | Jan 24, 2021 | Pending |
Array
(
[id] => 18021052
[patent_doc_number] => 20220372551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => METHODS FOR IDENTIFICATION OF LIGAND-BLOCKING ANTIBODIES AND FOR DETERMINING ANTIBODY POTENCY
[patent_app_type] => utility
[patent_app_number] => 17/795104
[patent_app_country] => US
[patent_app_date] => 2021-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13561
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17795104
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/795104 | Methods for identification of ligand-blocking antibodies and for determining antibody potency | Jan 21, 2021 | Issued |
Array
(
[id] => 18021052
[patent_doc_number] => 20220372551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => METHODS FOR IDENTIFICATION OF LIGAND-BLOCKING ANTIBODIES AND FOR DETERMINING ANTIBODY POTENCY
[patent_app_type] => utility
[patent_app_number] => 17/795104
[patent_app_country] => US
[patent_app_date] => 2021-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13561
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17795104
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/795104 | Methods for identification of ligand-blocking antibodies and for determining antibody potency | Jan 21, 2021 | Issued |
Array
(
[id] => 16992279
[patent_doc_number] => 20210230699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => Endometriosis Classifier
[patent_app_type] => utility
[patent_app_number] => 17/153789
[patent_app_country] => US
[patent_app_date] => 2021-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28407
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17153789
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/153789 | Endometriosis Classifier | Jan 19, 2021 | Abandoned |
Array
(
[id] => 18794175
[patent_doc_number] => 11827932
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-28
[patent_title] => Methods and compositions for nucleic acid sequencing
[patent_app_type] => utility
[patent_app_number] => 17/153309
[patent_app_country] => US
[patent_app_date] => 2021-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 12
[patent_no_of_words] => 21122
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17153309
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/153309 | Methods and compositions for nucleic acid sequencing | Jan 19, 2021 | Issued |
Array
(
[id] => 18511710
[patent_doc_number] => 20230227896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => Compositions, Kits and Methods for Isolating Target Polynucleotides
[patent_app_type] => utility
[patent_app_number] => 17/758906
[patent_app_country] => US
[patent_app_date] => 2021-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40600
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17758906
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/758906 | Compositions, Kits and Methods for Isolating Target Polynucleotides | Jan 14, 2021 | Pending |
Array
(
[id] => 18511710
[patent_doc_number] => 20230227896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => Compositions, Kits and Methods for Isolating Target Polynucleotides
[patent_app_type] => utility
[patent_app_number] => 17/758906
[patent_app_country] => US
[patent_app_date] => 2021-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40600
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17758906
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/758906 | Compositions, Kits and Methods for Isolating Target Polynucleotides | Jan 14, 2021 | Pending |
Array
(
[id] => 19651587
[patent_doc_number] => 12173361
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Rodent model and related device, compositions, methods and systems
[patent_app_type] => utility
[patent_app_number] => 17/148543
[patent_app_country] => US
[patent_app_date] => 2021-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 62
[patent_no_of_words] => 67106
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 466
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17148543
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/148543 | Rodent model and related device, compositions, methods and systems | Jan 12, 2021 | Issued |
Array
(
[id] => 16963264
[patent_doc_number] => 20210214763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => EMULSION BASED DRUG SCREENING
[patent_app_type] => utility
[patent_app_number] => 17/146994
[patent_app_country] => US
[patent_app_date] => 2021-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10246
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17146994
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/146994 | Emulsion based drug screening | Jan 11, 2021 | Issued |
Array
(
[id] => 16870569
[patent_doc_number] => 20210164036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => TRANSPOSASE-BASED GENOMIC ANALYSIS
[patent_app_type] => utility
[patent_app_number] => 17/136824
[patent_app_country] => US
[patent_app_date] => 2020-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12217
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17136824
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/136824 | Transposase-based genomic analysis | Dec 28, 2020 | Issued |
Array
(
[id] => 18972330
[patent_doc_number] => 20240052422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => IN-VITRO METHOD FOR DIAGNOSING AND PREDICTING THE AGGRESSIVENESS OF THYROID CANCER, AND THE PRECISION SURGERY OPTIONS AND TYPE TO BE USED TO REMOVE A TUMOUR FROM A PATIENT; KIT; REAGENTS FORMING THE KIT; AND USE OF THE REAGENTS AND USE OF MOLECULAR MARKERS AS PART OF THE METHOD
[patent_app_type] => utility
[patent_app_number] => 18/259139
[patent_app_country] => US
[patent_app_date] => 2020-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15396
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18259139
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/259139 | IN-VITRO METHOD FOR DIAGNOSING AND PREDICTING THE AGGRESSIVENESS OF THYROID CANCER, AND THE PRECISION SURGERY OPTIONS AND TYPE TO BE USED TO REMOVE A TUMOUR FROM A PATIENT; KIT; REAGENTS FORMING THE KIT; AND USE OF THE REAGENTS AND USE OF MOLECULAR MARKERS AS PART OF THE METHOD | Dec 23, 2020 | Pending |
Array
(
[id] => 16855220
[patent_doc_number] => 20210155965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => NUCLEIC ACID AMPLIFICATIONS
[patent_app_type] => utility
[patent_app_number] => 17/110714
[patent_app_country] => US
[patent_app_date] => 2020-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12781
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17110714
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/110714 | NUCLEIC ACID AMPLIFICATIONS | Dec 2, 2020 | Abandoned |
Array
(
[id] => 16750166
[patent_doc_number] => 20210102175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => SUPERCENTENARIAN INDUCED PLURIPOTENT STEM (sciPS) CELLS AND METHODS OF MAKING AND USING THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/110230
[patent_app_country] => US
[patent_app_date] => 2020-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11378
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17110230
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/110230 | Supercentenarian induced pluripotent stem (sciPS) cells and methods of making and using thereof | Dec 1, 2020 | Issued |
Array
(
[id] => 18150461
[patent_doc_number] => 20230024319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE
[patent_app_type] => utility
[patent_app_number] => 17/781469
[patent_app_country] => US
[patent_app_date] => 2020-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27938
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781469
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/781469 | METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE | Nov 30, 2020 | Pending |
Array
(
[id] => 18150461
[patent_doc_number] => 20230024319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE
[patent_app_type] => utility
[patent_app_number] => 17/781469
[patent_app_country] => US
[patent_app_date] => 2020-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27938
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781469
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/781469 | METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE | Nov 30, 2020 | Pending |
Array
(
[id] => 16855230
[patent_doc_number] => 20210155975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => METHOD AND SYSTEM FOR SAMPLING MATERIAL FROM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/105333
[patent_app_country] => US
[patent_app_date] => 2020-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19153
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17105333
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/105333 | Method and system for sampling material from cells | Nov 24, 2020 | Issued |